severe dry eye syndrome
Ophthalmology · 2018–2023
2decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| carmellose sodium with glycerol and hyaluronic acid Treatment of severe dry eye syndrome. | May 2023 | Recommended | none received |
| perfluorohexyloctane Treatment of severe dry eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops. | Mar 2018 | Recommended with restriction | unclear |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.